Every story in this section, newest first — page 130 of 373.
Genco Shipping & Trading (NYSE:GNK) issued a sharp public statement today dismantling what it calls "misleading disclosures" by its largest shareholder, Diana Shipping (NYSE:DSX), regarding its pending tender offer.
Apple (NASDAQ:AAPL) closed within roughly 4% of overtaking Nvidia (NASDAQ:NVDA) as the most valuable company in the United States, driven by fresh product pipeline optimization.
Nvidia (NASDAQ:NVDA) saw its equity valuation pull back to levels relative to its forward earnings capacity not seen since early 2019, before the generative artificial intelligence buildout reset broader capital market indices.
Chevron Technical Center, a division of Chevron U.S.A. (NYSE:CVX) and a subsidiary of Chevron Corporation, has finalized a technology licensing agreement allowing ZL Chemicals to commercialize its proprietary advanced chemical surfactant technology.
Baker Hughes (NASDAQ:BKR) and Kodiak Gas Services (NYSE:KGS) have finalized a multi-year strategic agreement to design and deploy custom gas turbine power solutions aimed at addressing rapid power constraints in U.S. data center and energy infrastructure markets.
Seres Therapeutics (NASDAQ:MCRB) reported positive early clinical data from a 15-patient investigator-sponsored study evaluating its microbiome candidate SER-155 in patients with immune checkpoint inhibitor-related enterocolitis.
Wrap Technologies, Inc. (NASDAQ:WRAP) announced a strategic transaction securing exclusive United States and NATO commercialization rights to Frenel Imaging’s physics-based artificial intelligence sensing technology.
Palladyne AI (NASDAQ:PDYN) reported preliminary financial results for the second quarter of fiscal 2026, with revenue increasing to approximately $5.8 million from $1 million in the same quarter of 2025.
OKYO Pharma (NASDAQ:OKYO) received positive regulatory feedback from the United States Food and Drug Administration following a Type D consultation to advance its ophthalmic candidate urcosimod into a global Phase 3 pivotal trial.
Prime Medicine (NASDAQ:PRME) secured a definitive binding arbitration victory against Beam Therapeutics regarding the clinical development rights for its Alpha-1 Antitrypsin Deficiency pipeline asset PM647.
UroGen Pharma (NASDAQ:URGN) received United States FDA clearance for its Investigational New Drug application to initiate clinical evaluations of its next-generation oncolytic virus treatment UGN-501.
Azenta (NASDAQ:AZTA) completed the sale of its B Medical Systems business to Thelema S.à r.l. on July 1, 2026.
Chemomab Therapeutics (NASDAQ:CMMB) and Scipher Medicine announced a stock-based merger agreement that will create Scipher Medicine Corporation, which is expected to trade under the ticker symbol “SCIP.”
BTQ Technologies (NASDAQ:BTQ) completed the acquisition of QPerfect, a France-based quantum software company, strengthening its Quantum Ready infrastructure platform.
Johnson & Johnson (NYSE:JNJ) secured United States FDA approval for its Dual Energy THERMOCOOL SMARTTOUCH SF Platform to treat increasingly complex cardiac cases using a single integrated catheter.
The United States Food and Drug Administration accepted a New Drug Application from Immunome (NASDAQ:IMNM) for its oral tumor treatment varegacestat following clinical trial data showing an 84% reduction in disease progression risk.
Odysight.ai (NASDAQ:ODYS) received a purchase order valued at approximately $0.3 million (NIS 1.0 million) from Elbit Systems to supply its specialized health monitoring software.
Sono-Tek (NASDAQ:SOTK) reported fiscal first-quarter 2027 results for the period ended May 31, 2026, with net sales increasing 10% to $5.66 million, mainly driven by demand from medical markets.
Diana Shipping (NYSE:DSX), the largest shareholder of Genco Shipping & Trading (NYSE:GNK), urged Genco investors to tender shares by July 10, 2026, at 5:00 p.m. Eastern Time under its acquisition proposal.
OR Royalties (NYSE:OR) generated 20,757 gold equivalent ounces in preliminary second-quarter asset deliveries to drive strong cyclical performance gains across its streaming portfolio.
AerCap Holdings (NYSE:AER) signed lease agreements with China Southern Group for three Boeing 777-300ERSF converted freighter aircraft to support the airline’s cargo operations.
BioLineRx (NASDAQ:BLRX) and Hemispherian reported positive preclinical data from a patient-derived ovarian cancer xenograft model showing a strong therapeutic synergy between its small-molecule candidate GLIX1 and the approved PARP inhibitor olaparib.
Keenova Therapeutics (NYSE:MNK) reported positive top-line Phase 3 clinical trial results for its injectable enzyme therapy XIAFLEX in adult patients suffering from progressive plantar fibromatosis.
Spire Global (NYSE:SPIR) successfully launched 10 satellites aboard SpaceX’s Transporter-17 rideshare mission, expanding its space-based data and intelligence capabilities.
